SE445013B - Medel for att forebygga eller behandla infektioner hos menniskor och djur - Google Patents

Medel for att forebygga eller behandla infektioner hos menniskor och djur

Info

Publication number
SE445013B
SE445013B SE7905523A SE7905523A SE445013B SE 445013 B SE445013 B SE 445013B SE 7905523 A SE7905523 A SE 7905523A SE 7905523 A SE7905523 A SE 7905523A SE 445013 B SE445013 B SE 445013B
Authority
SE
Sweden
Prior art keywords
groups
polymer
hydrophobic
water
infections
Prior art date
Application number
SE7905523A
Other languages
English (en)
Swedish (sv)
Other versions
SE7905523L (sv
Inventor
W E S Hjerten
T M Wadstrom
Original Assignee
Landstingens Inkopscentral
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20338361&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE445013(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Landstingens Inkopscentral filed Critical Landstingens Inkopscentral
Priority to SE7905523A priority Critical patent/SE445013B/sv
Priority to DE8080103218T priority patent/DE3071708D1/de
Priority to EP80103218A priority patent/EP0021230B2/fr
Priority to CA000354527A priority patent/CA1146865A/fr
Priority to JP8346880A priority patent/JPS567719A/ja
Publication of SE7905523L publication Critical patent/SE7905523L/
Priority to US06/575,160 priority patent/US4645757A/en
Publication of SE445013B publication Critical patent/SE445013B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SE7905523A 1979-06-21 1979-06-21 Medel for att forebygga eller behandla infektioner hos menniskor och djur SE445013B (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE7905523A SE445013B (sv) 1979-06-21 1979-06-21 Medel for att forebygga eller behandla infektioner hos menniskor och djur
DE8080103218T DE3071708D1 (en) 1979-06-21 1980-06-10 An agent for preventing or treating infections in human beings and animals
EP80103218A EP0021230B2 (fr) 1979-06-21 1980-06-10 Agent de prévention ou de traitement des infections chez les êtres humains et les animaux
CA000354527A CA1146865A (fr) 1979-06-21 1980-06-20 Agent utilise pour prevenir ou traiter les infections chez les humains et les animaux
JP8346880A JPS567719A (en) 1979-06-21 1980-06-21 Drug for prevention and remedy of infection
US06/575,160 US4645757A (en) 1979-06-21 1984-01-30 Agent for preventing or treating infections in human beings and animals

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7905523A SE445013B (sv) 1979-06-21 1979-06-21 Medel for att forebygga eller behandla infektioner hos menniskor och djur

Publications (2)

Publication Number Publication Date
SE7905523L SE7905523L (sv) 1980-12-22
SE445013B true SE445013B (sv) 1986-05-26

Family

ID=20338361

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7905523A SE445013B (sv) 1979-06-21 1979-06-21 Medel for att forebygga eller behandla infektioner hos menniskor och djur

Country Status (6)

Country Link
US (1) US4645757A (fr)
EP (1) EP0021230B2 (fr)
JP (1) JPS567719A (fr)
CA (1) CA1146865A (fr)
DE (1) DE3071708D1 (fr)
SE (1) SE445013B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8204244L (sv) * 1982-07-09 1984-01-10 Ulf Schroder Kristalliserad kolhydratsmatris for biologiskt aktiva substanser
SE460017B (sv) * 1984-03-14 1989-09-04 Landstingens Inkopscentral Bakterieadsorberande komposition i vattenoloeslig form
US5189015A (en) * 1984-05-30 1993-02-23 Alfa-Laval Agri International Ab Method for prophylactic treatment of the colonization of a Staphylococcus aureus bacterial strain by bacterial cell surface protein with fibronectin and fibrinogen binding ability
SE8801894D0 (sv) * 1988-05-20 1988-05-20 Alfa Laval Agri Int Fibronektinbindande protein
SE8901687D0 (sv) * 1989-05-11 1989-05-11 Alfa Laval Agri Int Fibronectin binding protein as well as its preparation
US5281414A (en) * 1989-07-28 1994-01-25 Stockel Richard F Three-dimensional water disinfectants
JP2911554B2 (ja) * 1990-06-25 1999-06-23 台糖株式会社 抗ウィルス剤
US5440014A (en) * 1990-08-10 1995-08-08 H+E,Uml/Oo/ K; Magnus Fibronectin binding peptide
JPH0751209B2 (ja) * 1991-06-06 1995-06-05 ベステクス株式会社 フィルタ材の製造方法
US5980908A (en) * 1991-12-05 1999-11-09 Alfa Laval Ab Bacterial cell surface protein with fibronectin, fibrinogen, collagen and laminin binding ability, process for the manufacture of the protein and prophylactic treatment
TW438608B (en) * 1995-08-02 2001-06-07 Hisamitsu Pharmaceutical Co A tablet containing anion exchange resin
DE19631421C2 (de) 1996-08-06 2002-07-18 Beiersdorf Ag Antimikrobielle Wundauflagen
JP4010585B2 (ja) * 1996-10-15 2007-11-21 久光製薬株式会社 陰イオン交換樹脂を含有する錠剤
US8519008B2 (en) 2003-01-22 2013-08-27 Purina Animal Nutrition Llc Method and composition for improving the health of young monogastric mammals
DK1635661T3 (da) * 2003-06-13 2010-12-20 Torkel Wadstroem Produkt til Absorptionsformål
DE102004035905A1 (de) * 2004-07-20 2006-02-16 Biotronik Vi Patent Ag Magnesiumhaltiges Wundauflagematerial
US9463119B2 (en) 2007-01-18 2016-10-11 Abigo Medical Ab Wound dressing with a bacterial adsorbing composition and moisture holding system
US8668899B2 (en) * 2009-11-13 2014-03-11 University Of Maryland, College Park Advanced functional biocompatible foam used as a hemostatic agent for compressible and non-compressible acute wounds
WO2013015738A1 (fr) 2011-07-22 2013-01-31 HJERTÉN, Maria Capture de bioparticules et de biopolymères pathogènes et non pathogènes
WO2015077742A2 (fr) * 2013-11-25 2015-05-28 University Of Maryland, Office Of Technology Commercialization Compositions de film polymère collant séchant rapidement, et procédés d'utilisation associés

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB386067A (en) * 1931-01-03 1933-01-12 Le Carbone Sa Improvements in or relating to dressings
NL255047A (fr) * 1959-08-21
US3130126A (en) * 1962-09-14 1964-04-21 Central Pharmacal Company Oral pharmaceutical products prepared with carboxymethyl benzyl dextran having a low carboxymethyl d. s. of 0.15
US3224941A (en) * 1963-01-21 1965-12-21 Lilly Co Eli Resin compositions and method for controlling diarrhea
GB1090421A (en) * 1963-12-13 1967-11-08 Aerosan Ltd Improvements in surgical dressings
US3545442A (en) * 1964-09-23 1970-12-08 Huyck Corp Bandaging and dressing material
FR5705M (fr) * 1966-08-31 1968-01-15
US3489148A (en) * 1966-12-20 1970-01-13 Procter & Gamble Topsheet for disposable diapers
US3624209A (en) * 1966-12-28 1971-11-30 Bristol Myers Co Composition for treatment of gastro-intestinal disorders
FR6901M (fr) * 1967-06-23 1969-04-28
US3903268A (en) * 1968-02-12 1975-09-02 Lescarden Ltd Chitin and chitin derivatives for promoting wound healing
FR2077687B1 (fr) * 1970-02-05 1973-03-16 Roussel Uclaf
US3911116A (en) * 1970-04-13 1975-10-07 Leslie L Balassa Process for promoting wound healing with chitin derivatives
US3914413A (en) * 1971-02-10 1975-10-21 Leslie L Balassa Process for facilitating wound healing with N-acetylated partially depolymerized chitin materials
US3943247A (en) * 1972-05-22 1976-03-09 Kaken Kagaku Kabushiki Kaisha Treatment of bacterial infections with glucan compositions
SE452109B (sv) * 1973-01-29 1987-11-16 Pharmacia Ab Rengoringsmedel for vetskande utvertes sarytor
SE413986B (sv) * 1973-03-23 1980-07-07 Exploaterings Ab Tbf Sett att separera amfipatiska emnen innehallande bade hydrofila och hydrofoba grupper samt gelprodukt for genomforande av separationen
FR2244543B1 (fr) * 1973-07-27 1977-07-01 Inst Nl Sante Rech Medica
US3965263A (en) * 1973-09-28 1976-06-22 The Purdue Frederick Company Choline salicylate compositions and methods for achieving analgesia
US4002173A (en) * 1974-07-23 1977-01-11 International Paper Company Diester crosslinked polyglucan hydrogels and reticulated sponges thereof
NL159285B (nl) * 1975-01-24 1979-02-15 Tevic Int Bv Vochtabsorberend produkt, voorzien van een laag vochtabsorberend materiaal en een vochtdoorlatende deklaag.
GB1541435A (en) * 1975-02-04 1979-02-28 Searle & Co Immunological materials
GB1544908A (en) * 1975-07-08 1979-04-25 Chembiomed Ltd Artificial oligosaccharide antigenic determinants
SE7702261L (sv) * 1976-03-02 1977-09-07 Pharmaco Inc Forfarande for att immobilisera antimikrobiella emnen
US4260602A (en) * 1977-08-16 1981-04-07 Burroughs Wellcome Co. Hapten polysaccharide conjugate medicaments and method of use
US4241054A (en) * 1978-12-08 1980-12-23 The Procter & Gamble Company Detoxifying lipophilic toxins

Also Published As

Publication number Publication date
SE7905523L (sv) 1980-12-22
EP0021230A3 (en) 1981-01-21
CA1146865A (fr) 1983-05-24
EP0021230A2 (fr) 1981-01-07
US4645757A (en) 1987-02-24
JPS567719A (en) 1981-01-27
JPH0152370B2 (fr) 1989-11-08
DE3071708D1 (en) 1986-09-25
EP0021230B1 (fr) 1986-08-20
EP0021230B2 (fr) 1990-07-25

Similar Documents

Publication Publication Date Title
SE445013B (sv) Medel for att forebygga eller behandla infektioner hos menniskor och djur
Marangon et al. Combination of rhamnolipid and chitosan in nanoparticles boosts their antimicrobial efficacy
Yin et al. Development of inherently antibacterial, biodegradable, and biologically active chitosan/pseudo-protein hybrid hydrogels as biofunctional wound dressings
Jain et al. A new horizon in modifications of chitosan: syntheses and applications
Kim Chitin and chitosan derivatives: advances in drug discovery and developments
Huang et al. Applications and perspectives of quaternized cellulose, chitin and chitosan: A review
US20110020227A1 (en) Polysaccharide-containing block copolmer particles and uses thereof
KR19990029034A (ko) 다당류 겔 조성물
Wang et al. Facile fabrication of bactericidal and antifouling switchable chitosan wound dressing through a ‘click’-type interfacial reaction
Kundu et al. Carboxymethyl cellulose–xylan hydrogel: synthesis, characterization, and in vitro release of vitamin B12
Gao et al. Construction of Antibacterial N‐Halamine Polymer Nanomaterials Capable of Bacterial Membrane Disruption for Efficient Anti‐Infective Wound Therapy
Nie et al. Controllable heparin-based comb copolymers and their self-assembled nanoparticles for gene delivery
Sahoo et al. Chitosan: The most valuable derivative of chitin
Kadhum et al. The synergistic effects of chitosan-alginate nanoparticles loaded with doxycycline antibiotic against multidrug resistant proteus mirabilis, Escherichia coli and enterococcus faecalis
Nath et al. Multifunctional mussel‐inspired Gelatin and Tannic acid‐based hydrogel with pH‐controllable release of vitamin B12
Trombino et al. Green chemistry principles for nano-and micro-sized hydrogel synthesis
Jaisankar et al. Dual property of chitosan blended copolymer membranes: Antidiabetic drug release profile and antimicrobial assay
Fernandes et al. Immobilization of antimicrobial core-shell nanospheres onto silicone for prevention of Escherichia coli biofilm formation
Shameli et al. Cross-linked Chitosan-Based Hydrogels Nanocomposites for Treatment of Disease
Wong et al. Grafted copolymerized chitosan and its applications as a green biopolymer
Jiang et al. A tough nanocomposite hydrogel for antifouling application with quaternized hyperbranched PEI nanoparticles crosslinking
Chen et al. From poly (vinylimidazole) to cationic glycopolymers and glyco-particles: effective antibacterial agents with enhanced biocompatibility and selectivity
JPH03167102A (ja) 抗菌剤
EP3052529B1 (fr) Fonctionnalisation et réticulation de l'acide hyaluronique
JP5623285B2 (ja) 抗菌性ポリマーおよびその組成物

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7905523-2

Format of ref document f/p: F